| Literature DB >> 35492791 |
Barkha Darra Wadhwani1, Deepak Mali1, Pooja Vyas1, Rashmy Nair2, Poonam Khandelwal1.
Abstract
Calotropis procera is locally known as Aak or Madar in Hindi, milk weed in English and belongs to the family Apocynaceae and subfamily Asclepiadoideae. Although a wasteland plant, it is of sacred use as its flowers are offered for worshipping Lord Shiva, a Hindu God. Tribes all over the world use the plant in treatment of various diseases like snake bite, body pain, asthma, epilepsy, cancer, sexual disorders, skin diseases and many more. This plant contains various phytoconstituents such as flavonoids, terpenoids, cardenolides, steroids oxypregnanes etc. Though literature searches reveal many reviews about ethnomedicinal uses, chemical composition and pharmacological activities, no recent papers are available that provide an overview of the therapeutic potential and toxicity of Calotropis procera. Hence, the insight of this review is to provide a systemic summary of phytochemistry, pharmacology, toxicology and therapeutic potential of Calotropis procera and to highlight the gaps in the knowledge so as to offer inspiration for future research. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35492791 PMCID: PMC9043578 DOI: 10.1039/d1ra06703f
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Ethnomedicinal applications of C. procera
| Plant part | Disease | Preparation/administration | References |
|---|---|---|---|
| Root/root bark | Amoebic dysentery | Paste with/without opium taken orally |
|
| Cholera | Powder orally taken or paste along with black pepper and ginger juice |
| |
| Dysentery | Powder orally taken |
| |
| Elephantiasis and hydrocele | Paste mixed with fermented rice water applied on the affected area |
| |
| Epilepsy | Grounded with goat milk and used as nasal drops |
| |
| Indigestion | Powder orally taken |
| |
| Jaundice | Taken with rice in grounded form |
| |
| Neuritis | Orally administered with cow butter |
| |
| Rheumatism | Powder taken with milk and sugar |
| |
| Snake bite | Powder orally taken. Paste applied on wounds and internally taken with ghee |
| |
| Spider and insect bite | Powdered and taken with vinegar |
| |
| Syphilis | Root bark powder taken orally |
| |
| Latex | Boils | Applied externally |
|
| Black scar on the face | Applied along with turmeric paste |
| |
| Ascites | Applied externally |
| |
| Liver and spleen disorder | Taken after dilution |
| |
| Leprosy | Applied on the affected area |
| |
| Migraine | Applied on the affected side vein of forehead |
| |
| Piles (haemorrhoids) | Applied externally |
| |
| Dog/jackal bite | Applied on wound |
| |
| Ring worm | Applied externally |
| |
| Scabies | Applied externally |
| |
| Snake bite | Applied on wounds or taken orally (20–30 drops for adults and 15–20 for infants) |
| |
| Five drops with 50 drops of distilled water injected hypodermally |
| ||
| Syphilis, leprosy and odema | Applied externally with sesame oil |
| |
| Tooth ache | Applied on affected tooth |
| |
| Vertigo | Applied on affected parts |
| |
| Leaf | Cold, cough, asthma and bronchitis | Warmed along with ghee and bandaged on the chest of infants |
|
| Calculus, liver and spleen disorder | Powder taken orally |
| |
| Ear ache or ear troubles | Juice along with fermented boiled rice water used as ear drops |
| |
| Eczema and skin eruptions | Applied externally along with turmeric and sesame oil |
| |
| Enlargement of abdominal viscera and spleen | Oral administration of powder |
| |
| Gonorrhoea | Decoction used for washing and taken orally |
| |
| Inflammatory swellings | Covered on affected part after warming |
| |
| Joint pain | Powder taken |
| |
| Malaria and intermittent fever | Oral administration of fresh juice |
| |
| Body pain | Paste applied after warming |
| |
| Paralysis and sciatica | Massaged after preparing decoction with sesame oil |
| |
| Snake bite | Oral administration of fresh juice |
| |
| Ulcers, wounds, sores | Powder orally administered or external application |
| |
| Flowers | Health tonic | Oral administration of powder |
|
| Cough | Burnt to produce ash, then taken with honey |
| |
| Rat bite | Oral administration of powder |
| |
| Dog/jackal bite (rabies) | Seven tepals chewed with fine rice on seventh day of biting, continued for seven days decreasing one tepal everyday |
| |
| Feet pain | Decoction used for fomentation |
| |
| Epilepsy | Oral administration of paste with black pepper |
| |
| Asthma and bronchitis | Fruit taken with jaggery |
| |
| Liver and spleen disorder | Administered along with milk |
| |
| Fruit | Eye disorder | Decanted ash water applied on eye lids |
|
| Anemia | Mixed with same quantity of red chilli, mineral salt and taken with milk. |
| |
| Whole plant | Rheumatic pain and hyperacidity | Paste directly taken |
|
| Young twigs | Purgative | Juice taken |
|
Brief summary of the pharmacological properties
| S. no. | Pharmacological activities | Parts/extracts/possible chemical constituents | References |
|---|---|---|---|
| 1 | Wound healing potential | Latex: aqueous extract |
|
| Latex |
| ||
| Bark: ethanolic extract |
| ||
| Leaves: aqueous extract |
| ||
| Bark: aqueous extract |
| ||
| 2 | Anticoccidial activity | Dried leaves powder |
|
| 3 | Toxicity activity | Leaves: aqueous extract |
|
| Leaves and stem bark extracts |
| ||
| Leaves and stem: ethanolic extract |
| ||
| Leaves: ethanolic extract |
| ||
| 4 | Biopesticidal/insecticidal activity | Leaves: extract |
|
| Leaves: methanolic extract, latex protein fraction, flavonoids (quercetin-3- |
| ||
| 5 | Antimycoplasmal activity | Leaves: acetone extract |
|
| 6 | Hepatoprotective activity | Root bark: methanolic extract |
|
| Flowers: hydroethanolic extract |
| ||
| Roots: chloroform extract |
| ||
| 7 | Antimicrobial/antibacterial activity | Leaves: methanolic extract, flavonoids (quercetin-3- |
|
| Leaves and latex: ethanol, aqueous, and chloroform extract |
| ||
| Leaves and stem: aqueous, ethanolic, methanolic extract |
| ||
| Endophytic fungi of |
| ||
| Seeds: chloroform extract |
| ||
| Root: pet. ether, methanolic extract |
| ||
| Flowers: ethanolic extract |
| ||
| Latex |
| ||
| Leaves: methanolic extract |
| ||
| Leaves, flower, root bark: ethanolic extract |
| ||
| Leaves and latex: aqueous, ethanolic extract |
| ||
| Leaves: aqueous, methanolic extract |
| ||
| Latex: aqueous extract |
| ||
| 8 | Central nervous system activity | Latex proteins |
|
| 9 | Antioxidant activity | Leaves, flower, fruit, latex |
|
| Leaves: aqueous, methanolic extract, quercetin and its derivatives |
| ||
| Leaves: aqueous and methanolic extract |
| ||
| Leaves, flowers and fruits: methanolic extract |
| ||
| Bark: ethanolic extract |
| ||
| 10 | Antinociceptive activity | Latex protein |
|
| 11 | Antihelmintic activity | Flowers: crude powder, aqueous and methanolic extract |
|
| Latex: fresh, dried aqueous extract |
| ||
| 12 | Antiinflammatory activity | Dry latex |
|
| Stem bark: chloroform and hydro-alcoholic extract |
| ||
| Latex: hexane, dichloromethane, ethyl acetate, |
| ||
| Latex: pet. ether, acetone, methanol extract |
| ||
| Leaves: aqueous extract |
| ||
| Flowers: ethanolic extract |
| ||
| 13 | Antidiarroheal activity | Bark: Arkamula Tvarka (Ayurvedic preparation) |
|
| Latex |
| ||
| 14 | Antifungal activity | Aqueous bark extract |
|
| Leaves: aqueous, methanol, acetone and ethanol extract |
| ||
| Root bark |
| ||
| Antimycotic activity against dermatophytes | Latex |
| |
| Antimycofloral activity (fungi in wheat) | Fresh latex |
| |
| 15 | Larvicidal activity | Crude latex and ethanolic extract of leaf |
|
| Leaves: ethanolic extract |
| ||
| Leaves: aqueous extract |
| ||
| Flower, young bud, mature leaves and stems: ethanolic extract |
| ||
| Flowers: aqueous extract |
| ||
| 16 | Tobacco mosaic virus (TMV) inhibitor activity | Latex |
|
| 17 | Antifertility activity | Ethanolic extract of roots |
|
| Leaves: ethanolic extract |
| ||
| Roots (calotropin) |
| ||
| Abortifacient activity | Latex |
| |
| Antisperm activity | Root: chloroform extract |
| |
| Oestrogenic/antiovulatory activity | Roots: ethanolic and aqueous extract |
| |
| 18 | Plasma clotting activity | Protein fraction isolated from fresh latex |
|
| 19 | Antiplasmodial activity | Different plant parts: ethyl acetate, ethanolic and acetone extract |
|
| Leaves extract |
| ||
| 20 | Antipyretic activity | Dry latex: aqueous extract |
|
| Flowers: ethanolic extract |
| ||
| 21 | Antiasthmatic activity | Flowers |
|
| 22 | Anticonvulsant activity | Root extracts |
|
| 23 | Cytotoxic activity | Root (2′′-oxovoruscharin) |
|
| Laticifer proteins (LP) recovered from latex |
| ||
| Root: methanolic, aqueous, ethyl acetate, hexane extracts |
| ||
| Plant: methanolic extract |
| ||
| Stems: uzarigenin |
| ||
| Root bark: calotroprocerol A |
| ||
| Root: alcoholic, hydro-aqueous and aqueous |
| ||
| Leaf: ethanolic extract |
| ||
| 24 | Analgesic activity | Flowers: Ethanolic extract |
|
| 25. | Antihyperglycemic activity | Leaves: pet ether, methanol and aqueous extracts |
|
| 26 | Antiarthritis activity | Latex |
|
| Protein sub fraction of latex |
| ||
| 27 | Antimolluscicidal activity | Latex: 95% aqueous ethanol (uscharin) |
|
| 28 | Antitermites activity | Latex |
|
| 29 | Antimigraine activity | Dried terminal leaves |
|
| 30 | Anti-ulcer activity | Root: chloroform extract |
|
| Plant: 50% ethanolic extract |
| ||
| Leaf: ethanolic extract |
| ||
| Stem bark: chloroform and hydroalcoholic extract |
| ||
| 31 | Spasmolytic activity | Plant: aqueous extract |
|
| 32 | Allelopathic activity | Leaves: aqueous extract |
|
| 33 | Anti-keloidal activity | Latex |
|
| 34 | Anti-hyperbilirubinemic activity | Leaves: aqueous extract |
|
| 35 | Antiapoptotic activity | Latex |
|
Summary of cytotoxic studies of C. procera
|
| Cancer cell lines/model | Method of analysis/assay | Mechanism of action/investigation | Observation | References |
|---|---|---|---|---|---|
| Uscharin and its derivatives | Lung cancer (A549) | MTT colorimetric assay, intraperitoneal (ip) injection-related toxicity | Na+/K+-ATPase inhibition activity | Cardenolides derived from 2′′-oxovoruscharin exhibited significant |
|
| 2′′-Oxovoruscharin and its derivatives | Two glioblastoma (Hs683, U373) and two colon cancer (HCT-15 and LoVo) | ||||
| Laticifer proteins (LP) recovered from latex | HL60 (promoyelocytic leukemia), HCT-8 (colon), MDA-MB-435(breast), SF-295(brain) | 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2 | LP is a target for DNA topoisomerase I triggering apoptosis in cancer cell lines | IC50 values for LP ranged from 0.42 to 1.36 μg mL−1 to SF-295, MDA-MB-435 respectively |
|
| Root: methanolic, aqueous, ethyl acetate, hexane extracts (1, 5, 10, 25 μg mL−1) | Human Hep 2 | Tetrazolium bromide (MTT), colorimetry | Treatment initiated apoptotic mechanism by blocking the cell cycle at S-phase and thus preventing cells from entering proliferative (G2/M) phase | Ethyl acetate extract showed strongest cytotoxic effect |
|
| Plant: methanolic extract (0, 5, 10, 20 and 40 μg mL−1) | Human skin melanoma cells (SK-MEL-2) | Annexin-V FITC flow cytometry method, MTS assay | Methanolic extract induced apoptosis as shown by the accumulation of cells in the G2/M phase and the decrease of cell percentage in the G0/G1 phase | At 40 μg mL−1 late apoptotic cell percentage was increased up to 80%. |
|
| 5-Hydroxy-3,7-dimethoxyflavone-4- | HT 29, HepG2 (human cancer cell lines), NIH-3T3 (mouse fibroblast cell line) | CellTiter-Blue® cell viability assay | — | Uzarigenin showed moderate cytotoxicity |
|
| Calotroprocerol A; calotroproceryl acetate A; calotroprocerone A, B; pseudo-taraxasterol acetate; taraxasterol; calotropursenyl acetate B; stigmasterol; ( | A549 non-small cell lung cancer (NSCLC), the U373 glioblastoma (GBM) and the PC-3 prostate cancer cell lines | 3-(4,5-Dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) assay | Growth inhibition action | Calotroprocerol A exhibited |
|
| Calotroposide H; calotroposide I; calotroposide J; calotroposide K; Calotroposide L; calotroposide M; calotroposide N | A549 non-small cell lung cancer (NSCLC), U373 glioblastoma (GBM), and PC-3 prostate cancer cell lines | MTT colorimetric assay | Calotroposide K and M exhibited subnanomolar growth inhibition activity with IC50 ranging from 0.5 to 0.7 μM against U373 glioblastoma (GBM) and PC-3 prostate cancer cell lines |
|
|
| Calotroposide S | PC-3 prostate cancer, A549 non-small cell lung cancer (NSCLC), and U373 glioblastoma (GBM) cell lines | MTT colorimetric assay | Calotroposide S showed potent anti proliferative activity |
|
|
| Latex: hexane, chloroform, ethyl acetate and aqueous extract. Calactin; 15β-hydroxy calactin; afroside; uscharin; 15β-hydroxy uscharin; calotoxin; 12β-hydroxycoroglaucigenin; afrogenin; calactoprocin; procegenin A; procegenin B | A549 (lung) and hela (cervix) cancer cell lines using cisplatin as a positive control | MTT colorimetric assay | Growth inhibition action | Highest cytotoxic activity was displayed by chloroform extract. Amongst isolated compounds, calactin displayed highest cytotoxic activity |
|
| Root: alcoholic, hydro-aqueous and aqueous extracts(10 μg mL−1, 30 μg mL−1, 100 μg mL−1) | Human oral (KB) and central nervous system (SNB-78) cancer cell lines | Sulforhodamine-B (SRB) assay | Alcoholic extract showed significant growth inhibition action |
|
|
Summary of in vivo studies of wound healing potential of C. procera
| Model |
| Negative control | Investigation | Result | References |
|---|---|---|---|---|---|
| Guinea pigs | 20 mL of 1.0% sterile solution of the latex twice daily for 7 days | Excision wounds | Wounds exhibited marked dryness, no visual sign of inflammation | Significant prohealing property |
|
| Male albino-Wistar rats | Ethanolic extract of bark (50 mg per wound) | Incision and excision wounds | Extract demonstrated wound healing effect by accelerating wound closure and epithelialization | Excellent dermal wound healing potential |
|
| Wistar rats | Aqueous extract of | Incision and excision wounds | Significant ( | Significant wound healing property |
|
Summary of in vivo anti-inflammatory potential of C. procera
| Model |
| Negative control | Investigation | Result | References |
|---|---|---|---|---|---|
| Male albino rats and albino guinea pigs | 50 mg, 200 mg 500 mg and 1 g kg−1 dry latex | Carrageenan-induced oedema test, cotton pellet granuloma and vascular permeability | Dry latex suppressed fluid exudation, due to its influence on vascular permeability and also delayed the onset and intensity of UV induced erythema | Significant anti-inflammatory potential |
|
| Male albino rats | Dry latex | Carrageenin and formalin-induced pedal oedema test | At dose 5 mg per rat, showed 71% inhibition in the case of the carrageenin-induced oedema ( | Potent anti-inflam-matory activity |
|
| Albino rats of either sex | Stem bark: chloroform and hydro-alcoholic extract | Carrageenan-induced paw oedema | Significant reduction in the inflammation at 100, 200 and 400 mg kg−1 displayed by chloroform extract | Significant anti-inflammatory potential |
|
| Male Wistar rats | Dry latex: petroleum ether, acetone, methanol and aqueous extracts (50 mg per rat) | Carrageenan induced paw oedema | Maximum anti-inflammatory effect (59% and 53% inhibition) by the aqueous and acetone extracts respectively compared to (63%) inhibition exhibited by phenylbutazone | Latex of |
|
| Male Wistar rats | Crude latex: hexane, dichloromethane, ethyl acetate, | Carrageenan-induced peritonitis | Dichloromethane, ethyl acetate, and aqueous fractions inhibited carrageenan-induced neutrophil migration in rats at the ratios 67%, 56%, and 72%, respectively | Latex of |
|
Summary of larvicidal potential of C. procera
| Vector species |
| Observation | Result | References |
|---|---|---|---|---|
|
| Crude latex and ethanolic extract of leaves | 100% larval mortality at 300 ppm concentration of latex and at 1000 ppm concentration of ethanolic leaf extract. LC50 values of the latex and ethanolic leaves extract were 57.3 and 388.7 ppm respectively | Crude latex exerted stronger larvicidal potential than ethanolic extract |
|
|
| Ethanolic extract of leaves (500 mg L−1) | 100% mortality at 500 ppm. LC50 value of the extract 282.5 ppm | Leaves exerted insecticidal potential |
|
|
| Aqueous extract of leaves (1000, 500, 200 ppm) | LC50 value 273.53, 366.44, 454.99 ppm for 2nd, 3rd and 4th instar larvae | Leaves showed oviposition deterrent, larvicidal and adult emergence activity |
|
|
| Ethanolic extracts of different parts | Mature leaves extract exhibited 100% mortality at 2000 ppm after 48 hours of incubation | Mature leaves showed high larvicidal activity against tested larvae |
|
|
| Aqueous extract of flowers (1%, 2.5% and 5%)/24 h | At 1% concentration, the mortality rate was 0%, 60% and 100% and at 2.5% concentration, mortality rate was 20%, 80% and 100% at the end of 1, 3 and 4 days of exposure, and at 5% concentration, 100% mortality was recorded at the end of third day | Flowers exhibited remarkable larvicidal properties against the pupae and late 4th instar larvae of |
|
Summary of in vivo and in vitro studies of anthelmintic potential of C. procera
| Model |
| Compared with drug | Observation | Result | References |
|---|---|---|---|---|---|
|
| Crude powder (CP), crude aqueous (CAE) and crude methanolic extracts (CME) | Levamisole | 88.4%, 77.8% and 20.9% reduction in egg count percent for CAE, CP and CME respectively | Aqueous extract of |
|
| Earthworms | Aqueous extract of dry latex (5, 10, 50 and 100 mg mL−1) and fresh latex (1.45, 7.25, 29, 72.5 and 145 mg mL−1) | Piperazine | At 5 to 10 mg mL−1 concentration paralysis at 90 min, at 100 mg mL−1 death within 60 min. Fresh latex also showed dose-dependent paralysis | Latex showed wormicidal activity, hence can be used as an anthelmintic agent |
|
Summary of in vitro studies of antioxidant potential of C. procera
|
| Extract/dose/duration | Investigation | Result | References |
|---|---|---|---|---|
| Leaves, fruits, flowers and latex | Methanolic solution of dried extract | DPPH radical scavenging assay | Leaves exhibited maximum DPPH radical scavenging activity with IC50 = 0.18 mg mL−1, whereas latex showed minimum activity with IC50 = 0.42 mg mL−1 |
|
| Leaves | Aqueous and methanolic extract (1, 5, 10, 50, 100 and 500 μg mL−1) | DPPH radical scavenging assay | IC50 of the methanol extract was 110.25 μg mL−1, the aqueous extract showed mild antioxidant activity |
|
| Leaves | 2–100 mg mL−1 for quercetin in methanol and 20–100 mg mL−1 for AME and quercetin derivatives with different methoxy substitution | DPPH radical scavenging assay | Varying degrees of antioxidant activity was exerted by quercetin derivatives, but quercetin was found to be most active |
|
| Leaves, flowers and fruits | Methanolic extracts of the samples of different concentrations (100–1000 ppm) | DPPH radical scavenging assay | IC50 values in leaves, fruits and flowers were 16.08, 16.06 and 10.31 μg mL−1 respectively, showing strong antioxidant activity of |
|
Summary of in vitro schizontocidal activity of C. procera
| Model |
| Investigation | Result | References |
|---|---|---|---|---|
| Chloroquine sensitive strain, MRC 20 and a chloroquine resistant strain, MRC 76 of | Ethyl acetate, acetone, methanol fractions of flower, bud, root: (62–125 mg mL−1) | Percentage inhibition varied from 7.51 to 61.38% between the various fractions against MRC 20 and for MRC 76, percentage inhibition varied from 3.437 to 41.08% between the various fractions | At the lower dose range, the root extracts of |
|
Summary of in vivo hepatoprotective potential of C. procera
| Model |
| Negative control | Investigation | Result | References |
|---|---|---|---|---|---|
| Albino rats of either sex | Methanol extract (MCP) of root and its sub fractions | Carbon tetra chloride | MCP and its sub fractions HCP, ECP displayed hepatoprotective effect by reducing the elevated serum levels of, serum glutamic pyruvic transaminase, alkaline phosphatase and serum glutamic oxaloacetic transaminase, it increased high density lipoprotein. CCP does not show effective results |
|
|
| Wistar rats of either sex | Hydro-ethanolic extract of | Paracetamol-induced hepatitis | Improvement in the hepatic architecture was observed |
|
|
Compounds isolated from Calotropis procera
| S. No. | Compound name (molecular formula) | Extract/fraction | Eluent | Plant part & references |
|---|---|---|---|---|
|
| ||||
| 1 | 5-Hydroxy-3,7-dimethoxyflavone-4′- | Ethanolic extract | Benzene-chloroform | Stem[ |
| 2 | Isorhamnetin 3- | 85% methanolic extract | 10–40% methanol | Leaves[ |
| 3 | Isorhamnetin 3- | 85% methanolic extract | 10–40% methanol | Leaves[ |
| 4 | Isoquercitrin (C21H20O12) | 85% methanolic extract | 70% methanol | Leaves[ |
| 5 | Quercetagetin-6-methyl ether 3- | 85% methanolic extract | 40–60% methanol | Leaves[ |
| 6 | Quercetin (C15H10O7) | 85% methanolic extract | 80% methanol | Leaves[ |
| 7 | Isorhamnetin (C16H12O7) | 85% methanolic extract | 80% methanol | Leaves[ |
| 8 | Azaleatin (C16H12O7) | 85% methanolic extract | 80% methanol | Leaves[ |
| 9 | 3,3′-Dimethoxy quercetin (C17H14O7) | 85% methanolic extract | 50–60% ethyl acetate | Leaves[ |
| 10 | 3,6,3′,4′-Tetramethoxy quercetin (C18H16O7) | 85% methanolic extract | 50–60% ethyl acetate | Leaves[ |
| 11 | 3,6,7,3′,4′-Pentamethoxy quercetin (C19H18O7) | 85% methanolic extract | 60–100% ethyl acetate | Leaves[ |
| 12 | Kaempferol-3- | Methanolic extract | Ethyl acetate : water : formic acid : glacial acetic acid (100 : 26 : 11 : 11, v/v) | Leaves[ |
| 13 | Quercetin-3- | Methanolic extract | Ethyl acetate : water : formic acid : glacial acetic acid (100 : 26 : 11 : 11, v/v) | Leaves[ |
| 14 | Luteolin (C15H10O6) | Ethanol–water extract (60 : 40)/butanol fraction |
| Stem bark[ |
| 15 | Epicatechin (C15H14O6) | Ethanol–water extract (60 : 40)/butanol fraction |
| Stem bark[ |
| 16 | Kaempferol 3- | Ethanolic extract | Water–methanol (1 : 1) | Fruits[ |
|
| ||||
| 17 | Stigmasterol (C29H48O) | Methanolic extract/hexane fraction | Hexane–ethyl acetate | Flowers,[ |
| 18 | β-Sitosterol (C29H50O) | Ethanolic extract/chloroform fraction | Hexane–ethyl acetate | Flowers,[ |
| 19 | Daucosterol or β-sitosterol glucoside (C35H60O6) | Ethanolic extract/chloroform fraction | 10% aq. methanol and hexane | Latex, aerial part,[ |
| 20 | Benzoyllineolone (C28H36O6) | Ether extract/chloroform fraction | Benzene–chloroform | Root bark[ |
| 21 | Benzoylisolineolone (C28H36O6) | Ether extract/chloroform fraction | Benzene–chloroform | Root bark[ |
| 22 | Lineolone (C21H32O5) | Ether extract | — | Root bark[ |
| 23 | Isolineolone (C21H32O5) | Ether extract | — | Root bark[ |
| 24 | Cyclosadol (C31H52O) | Methanolic extract | — | Flowers[ |
| 25 | β-Sitost-4-en-3-one (C29H48O) | Methanolic extract |
| Flowers[ |
|
| ||||
| 26 | Calactin (C29H40O9) | Ethanolic extract/chloroform fraction | 10% aq. methanol and hexane | Roots,[ |
| 27 | 15β-Hydroxycalactin (C29H40O10) | Ethanolic extract/chloroform fraction | — | Latex[ |
| 28 | Calactoprocin or 14β,15β-dihydroxy-19-oxo-2α,3β-[(2 | Ethanolic extract/chloroform fraction | — | Latex[ |
| 29 | Afroside (C29H42O9) | Ethanolic extract/chloroform fraction | — | Latex[ |
| 30 | Calotoxin (C29H40O10) | Ethanolic extract/chloroform fraction | — | Aerial part,[ |
| 31 | Calotropin (C29H40O9) | Ethanolic extract/chloroform fraction | — | Root bark,[ |
| 32 | 12β-Hydroxycoroglaucigenin (C23H34O6) | Ethanolic extract/chloroform fraction | — | Latex[ |
| 33 | Procegenin A or 3α,12β,14β-trihydroxy-19-hydroxymethyl-5α-card-20(22)-enolide or 3- | Ethanolic extract/chloroform fraction | — | Latex[ |
| 34 | Procegenin B or 3α,12β,14β-trihydroxy-19-oxo-5α-card-20 (22)-enolide or 12β-hydroxy carpogenin (C23H32O6) | Ethanolic extract/chloroform fraction | — | Latex[ |
| 35 | Afrogenin (C23H34O6) | Ethanolic extract/chloroform fraction | — | Latex[ |
| 36 | Desglucouzarin (C29H44O9) | Ethanolic extract/chloroform : ethyl acetate fraction | Chloroform–methanol (9 : 1) | Stem[ |
| 37 | Frugoside (C29H44O9) | Ethanolic extract/chloroform : ethyl acetate fraction | Chloroform–methanol (9 : 1) | Seeds,[ |
| 38 | Uzarigenin (C23H34O4) | Ethanolic extract/chloroform : ethyl acetate fraction | Chloroform–methanol (9.5 : 0.5) | Latex[ |
| Stem[ | ||||
| 39 | Uzarigenone (C23H32O4) | Ethanolic extract/benzene | Chloroform–methanol (9.5 : 0.5) | Stem[ |
| 40 | β-Anhydroepidigitoxigenin-3β- | Ethanolic extract/benzene : chloroform | Chloroform–methanol (9 : 1) | Stem[ |
| 41 | β-Anhydroepidigitoxigenin or 3β-hydroxy-5α-carda-14(15),20(22)-dienolide (C23H32O3) | Ethanolic extract → benzene : chloroform | Chloroform–methanol (9 : 2) | Stem[ |
| 42 | Calotropagenin (C23H32O6) | Chloroform extract | Hexane–diethyl ether (9 : 11) | Aerial part[ |
| 43 | Ischarin (C31H41NO8S) | Ethanolic extract | Chloroform | Aerial part[ |
| 44 | Ischaridin (C29H42O8) | Ethanolic extract/10% aq. methanol and hexane fraction | Chloroform–methanol (98 : 2) | Aerial part[ |
| 45 | 2′′-Oxovoruscharin (C31H41NO9S) | Methanolic extract | Dichloromethane–methanol (98 : 2) | Root bark[ |
| 46 | Proceraside A (C31H44O10) | Methanolic extract/ethyl acetate fraction | Chloroform–methanol | Root bark[ |
| 47 | Syriogenin (C23H34O5) | Methanolic extract | Water–methanol | Latex[ |
| 48 | Proceroside (C29H40O10) | Methanolic extract | Water–methanol | Latex[ |
| 49 | Uscharidin (C29H38O9) | Ethanolic extract | — | Aerial part[ |
| 50 | Voruscharin (C31H43NO8S) | Methanolic extract | Acetone–methanol (8 : 2) | Roots[ |
| 51 | Coroglaucigenin (C23H34O5) | Chloroform extract | — | Seeds[ |
| 52 | Corotoxigenin (C23H32O5) | Ether extract | — | Seeds[ |
| 53 | 3-[β-(4- | 70% ethanolic extract/benzene : chloroform | Chloroform–methanol (9 : 1.5) | Stem[ |
| 54 | Uzarin or 3-[β-(2- | 70% ethanolic extract/benzene : chloroform | Chloroform–methanol (9 : 2) | Stem[ |
| 55 | 15β-Hydroxyuscharin (C31H41NO9S) | Ethanolic extract | Chloroform | Latex[ |
| 56 | Uscharin (C31H41NO8S) | Methanolic extract | Chloroform–methanol (70 : 30) | Aerial part,[ |
| 57 | Proceragenin or 7β,14β-dihydroxy-5α-card-20(22)-enolide (C23H34O4) | Methanolic extract/chloroform fraction | Hexane–chloroform (1 : 9) | Aerial part[ |
| 58 | 2β,19-Epoxy-3β,14β-dihydroxy-19-methoxy-5-α-card-20(22)-enolide (C24H34O6) | Ethanolic extract/benzene : chloroform fraction | Chloroform–methanol (9 : 2) | Stem[ |
| 59 | Procesterol or (24 | Ethanolic extract/chloroform fraction | Hexane–chloroform (3 : 2) | Fresh and undried flowers[ |
|
| ||||
| 60 | α-Amyrin (C30H50O) | Methanolic extract/hexane : ethyl acetate gradients | Dichloromethane–methanol (1 : 1) | Flowers[ |
| 61 | β-Amyrin (C30H50O) | Methanolic extract/hexane : ethyl acetate gradients | Dichloromethane–methanol (1 : 1) | Flowers[ |
| 62 | α-Amyrin acetate (C32H52O2) | Methanolic extract | Pet. ether–chloroform (1 : 9) | Roots[ |
| 63 | Procerursenyl acetate or urs-18α- | Methanolic extract | Pet. ether–chloroform (1 : 1) | Roots[ |
| 64 | Calotropenyl acetate or urs-19(29)-3β-yl acetate (C32H52O2) | Chloroform extract | Benzene–hexane (60 : 40) | Flower,[ |
| 65 | Calotropoleanyl ester or olean-13(18)-en-3β-yl acetate (C32H52O2) | Ethanolic extract | Pet. ether | Root bark[ |
| 66 | Calotroprocerol A or ursa-5,12,20(30)-trien-18αH-3β-ol (C30H46O) | Methanolic extract |
| Root bark[ |
| 67 | Calotroproceryl acetate A or ursa-5,12,20(30)-trien-18α | Methanolic extract |
| Root bark[ |
| 68 | Calotroprocerone A or ursa-5,12,20(30)-trien-18α | Methanolic extract |
| Root bark[ |
| 69 | Calotroproceryl acetate B or ursa-5,12,20-trien-18α | Methanolic extract |
| Root bark[ |
| 70 | Calotropursenyl acetate B or urs-12,19(29)-diene-3β-yl acetate (C32H50O2) | Methanolic extract |
| Root bark[ |
| 71 | Pseudo-taraxasterol acetate (C32H52O2) | Methanolic extract |
| Root bark[ |
| 72 | Taraxasterol (C30H50O) | Methanolic extract |
| Root bark[ |
| 73 | Proceroleanenol A or olean-13(18)-en- 9α-ol (C30H50O) | Ethanolic extract | Benzene–chloroform | Root bark[ |
| 74 | Proceroleanenol B or olean-5,13(18)-dien-3α-ol (C30H48O) | Ethanolic extract | Benzene–chloroform (1 : 1) | Root bark[ |
| 75 | Cycloart-23-ene-3β,25-diol (C30H50O2) | Ethyl acetate extract | Hexane–ethyl acetate (2 : 1) | Flowers[ |
| 76 | Lupeol (C30H50O) | Ethanolic extract | — | Latex[ |
| 77 | 3- | Ethanolic extract | — | Latex[ |
| 78 | Multiflorenol (C30H50O) | Pet. ether fraction | Chloroform–ethyl acetate (3 : 2) | Flowers,[ |
| 79 | Urs-19(29)-en-3-β-ol (C30H50O) | Acetone fraction | Pet. ether–acetone (8 : 2) | Latex[ |
| 80 | Calotropenyl acetate or urs-19(29)-en-3-yl acetate (C32H52O2) | Pet. ether fraction | Chloroform–ethyl acetate (3 : 5) | Latex[ |
| 81 | 3β,27-Dihydroxy-urs-18-en-13,28-olide (C30H46O4) | Ethyl acetate fraction | Benzene–ethyl acetate (8 : 2) | Latex[ |
| 82 | Calotropfriedelenyl acetate or friedelin-1-ene-3 β-yl acetate (C32H52O2) | Ethanolic extract | — | Root bark[ |
| 83 | Calotropterpenyl ester or 6,10,14-trimethylpentadec-6-enyl-2′,4′,8′,12′,16′-pentamethyl nonadecane ester (C42H82O2) | Ethanolic extract | — | Root bark[ |
| 84 | Phytyl iso-octyl ether or 3,7,11,15-tetramethyl hexadecanyl-6′-methyl hept-5′-enyl ether (C28H56O) | Methanolic extract | Pet. ether–chloroform (1 : 3) | Roots[ |
| 85 | Dihydrophytoyl tetraglucoside or 3,7,11,15 tetramethylhexadecanoyl-β- | Methanolic extract | Chloroform–methanol (3 : 2) | Roots[ |
| 86 | Procerasesterterpenoyl triglucoside or 2,6,10,14,18-pentamethylnonadecanoyl-β- | Methanolic extract | Chloroform–methanol (3 : 1) | Roots[ |
| 87 | Oleanolic acid (C30H48O3) | Chloroform extract/butanol fraction | Benzene–ethyl acetate (10 : 1–1 : 10) | Stem bark[ |
| 88 | Lupeol-3- | Ethanolic extract | Chloroform–methanol (9.3 : 0.7) | Leaves[ |
| 89 | Proceraursenolide or 18-α | Ethanolic extract | Pet. ether–chloroform (1 : 3) | Roots[ |
|
| ||||
| 90 | Calotroposide H or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 91 | Calotroposide I or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 92 | Calotroposide J or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 93 | Calotroposide K or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 94 | Calotroposide L or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 95 | Calotroposide M or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 96 | Calotroposide N or 12- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
| 97 | Calotroposide S or 12-benzoylisolineolon-3- | Methanolic extract/ | Chloroform–methanol (85 : 15) | Root bark[ |
|
| ||||
| 98 | Methyl resorcinyl triglycoside or | Methanolic extract | Chloroform–methanol (3 : 2) | Roots[ |
| 99 | Butanediol diglucuronoside or ( | Methanolic extract | Chloroform–methanol (4 : 1) | Roots[ |
| 100 | ( | 85% methanolic extract | 40–60% aqueous methanol | Leaves[ |
| 101 | Methyl 4- | Ethanolic extract | Water–methanol (1 : 1) | Flowers[ |
|
| ||||
| 102 | 7′-Methoxy-3′- | Ethanolic extract | Water–methanol (6 : 4) | Flowers[ |
| 103 | Pinoresinol-4- | Ethanolic extract | Water–methanol (1 : 1) | Flowers[ |
| 104 | Syringaresinol-4- | Ethanolic extract | Water–methanol (1 : 1) | Fruits[ |
|
| ||||
| 105 | Labdan-18-ol-β- | Methanolic extract | Chloroform–methanol (9 : 1) | Roots[ |
| 106 | Proceralabdanoside/labdan-3β-ol-11,15-olide-18,20-dioic acid-3β- | Methanolic extract | Chloroform–methanol (9 : 1) | Roots[ |
|
| ||||
| 107 | Methyl caffeate (C10H10O4) | 85% methanolic extract | 30–50% aqueous methanol | Leaves[ |
| 108 | Caffeic acid (C9H8O4) | 85% methanolic extract | 30–50% aqueous methanol | Leaves[ |
| 109 | Rosmarinic acid (C18H16O8) | Ethanolic extract | Chloroform–methanol (8.5 : 1.5) | Flowers[ |
| 110 | Methyl rosmarinate (C19H18O8) | Ethanolic extract | Chloroform–methanol (8.5 : 1.5) | Flowers[ |
|
| ||||
| 111 | 2-Propenyl-2 | — | — | Leaves[ |
| 112 | Glyceryl mono-oleolyl-2-phosphate (C21H41O7P) | Methanolic extract | Pet. ether–chloroform (1 : 3) | Roots[ |
| 113 | Methyl behenate (C23H46O2) | Methanolic extract | Chloroform–methanol (99 : 1) | Roots[ |
| 114 |
| Methanolic extract | Pet. ether–chloroform (3 : 1) | Roots[ |
| 115 | Methyl myrisate (C15H30O2) | Methanolic extract | Chloroform | Roots[ |
| 116 | Glyceryl-1,2-dicapriate-3-phosphate (C23H45O8P) | Methanolic extract | Chloroform–methanol (97 : 3) | Roots[ |
| 117 | ( | Methanolic extract/ |
| Root bark[ |
| 118 | Proceranol or | Methanolic extract | Chloroform–methanol (99 : 1) | Roots[ |
| 119 | Methyl ferulate | Methanolic extract | Chloroform–methanol (8.5 : 1.5) | Flowers[ |
| 120 | 1,2-Dihexadecanoyl-3-phosphatyl glycerol (C35H69O8P) | Methanolic extract | Chloroform–methanol (99 : 1) | Roots[ |
| 121 |
| Methanolic extract | Pet. ether–chloroform (1 : 3) | Roots[ |
| 122 | Tricapryl glyceride (C33H62O6) | Methanolic extract | Pet. ether | Roots[ |
| 123 | Oleodipalmityl glyceride (C53H100O6) | Methanolic extract | Pet. ether–chloroform (9 : 1) | Roots[ |
| 124 | Tribehenyl glyceride (C69H134O6) | Methanolic extract | Pet. ether–chloroform (1 : 1) | Roots[ |
| 125 | Capryl glucoside/ | Methanolic extract | Chloroform–methanol (49 : 1) | Roots[ |
| 126 | Palmityl glucoside/ | Methanolic extract | Chloroform–methanol (19 : 1) | Roots[ |
| 127 | Stearyl glucoside/ | Methanolic extract | Chloroform–methanol (93 : 7) | Roots[ |
| 128 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 129 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 130 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 131 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 132 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 133 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 134 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 135 | Methyl nonanotetracnoate (C10H12O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 136 |
| Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 137 | 9-Decenoate (C11H20O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 138 | Undecadienoate (C12H20O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 139 | 9-Dodecenoate (C13H24O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 140 | Tridecatrienoate (C14H22O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 141 | 2,4,5-Tetradecatrienoate (C15H24O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 142 | Hiragonate (C17H28O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 143 | Heptadecadienoate (C18H22O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 144 | Heptadecenoate (C18H38O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 145 | 9-Eicosenoate/gadoleate (C21H40O2) | Ethanolic extract | Hexane–chloroform | Aerial part[ |
| 146 | Gallic acid (C7H6O5) | Ethanolic extract | HPLC analysis | Aerial part[ |
| 147 | Ferulic acid (C10H10O4) | Ethanolic extract | HPLC analysis | Aerial part[ |
| 148 |
| Ethanolic extract | HPLC analysis | Aerial part[ |
| 149 | Vanillic acid (C8H8O4) | Ethanolic extract | HPLC analysis | Aerial part[ |
| 150 | Rutin (C27H30O16) | Ethanolic extract | HPLC analysis | Aerial part[ |
| 151 | 4-Hydroxy-4-methylpentan-2-one (C6H12O2) | Acetone extract | GC-MS analysis | Latex[ |
| 152 | 2,3,4-Trimethylhexane (C9H20) | Acetone extract | GC-MS analysis | Latex[ |
| 153 | Decane (C10H22) | Acetone extract | GC-MS analysis | Latex[ |
| 154 |
| Acetone extract | GC-MS analysis | Latex[ |
| 155 | 2,6-Dimethyl tetra-1,5-decaene (C16H28) | Acetone extract | GC-MS analysis | Latex[ |
| 156 |
| Acetone extract | GC-MS analysis | Latex[ |
| 157 | 3,7,11-Trimethyl-2,6,10,12-pentadecatrien-1-ol (C18H30O) | Acetone extract | GC-MS analysis | Latex[ |
| 158 | 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene (C30H50) | Acetone extract | GC-MS analysis | Latex[ |
| 159 | 1,3,5-Tri-isopropylbenzene (C15H24) | Acetone extract | GC-MS analysis | Latex[ |
| 160 | 6,10,14-Trimethyl-pentadecanone-2 (C18H36O) | Hexane extract | GC-MS analysis | Leaves[ |
| 161 | 9-Octadecenoic acid ( | Hexane extract | GC-MS analysis | Leaves[ |
| 162 | (6 | Hexane extract | GC-MS analysis | Leaves[ |
| 163 | Farnesol isomer (C15H26O) | Hexane extract | GC-MS analysis | Leaves[ |
| 164 | Tetratetracontane (C44H90) | Hexane extract | GC-MS analysis | Leaves[ |
| 165 | Ergost-5-en-3-ol (C28H48O) | Hexane extract | GC-MS analysis | Leaves[ |
Fig. 1Chemical structures of flavonoids.
Fig. 2Chemical structures of steroids.
Fig. 3Chemical structures of cardenolides.
Fig. 4Chemical structures of terpenoids.
Fig. 5Chemical structures of oxypregnanes.
Fig. 6Chemical structures of glycosides.
Fig. 7Chemical structures of lignan glycosides.
Fig. 8Chemical structures of terpene glycosides.
Fig. 9Chemical structures of caffeic acid derivatives.